Taro Pharmaceutical Industries (NYSE: TARO)
Some price data may be temporarily unavailable.
Key Data Points
Taro Pharmaceutical Industries Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Taro Pharmaceutical Industries Company Info
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
News & Analysis
Why Shares of Taro Pharmaceutical Are Rising Tuesday
The company is mulling a buyout offer from Sun Pharmaceutical.
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
3 Drug Stocks With the Highest Profit Margins
These drugmakers really know how to maximize every dollar they receive in sales!
3 Cheap Growth Stocks You Can Buy Right Now
These three growth stocks are cheap now, but they might not stay cheap for much longer.
Financial Health
General
Q1 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q1 2024 | YoY Change |
---|
Liabilities
Q1 2024 | YoY Change |
---|
Ratios
Q1 2024 | YoY Change |
---|
Cash Flow
Q1 2024 | YoY Change |
---|
Valuation
Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.